Previous Article | Next Article ![]()
Infect Immun, January 1998, p. 343-346, Vol. 66, No. 1
Medical Experimental
Center,1
Institute of Medical
Microbiology and Hygiene,2 and
Paul-Flechsig-Institute of Brain
Research,
Received 22 July 1997/Returned for modification 3 September
1997/Accepted 24 October 1997
The passage of radioiodinated streptolysin-O (SLO) and albumin
through the round window membrane (RWM) was studied in vivo. When
applied to the middle ear, SLO became quantitatively entrapped in this
compartment and no passage to the cochlea occurred. However, flux of
radioiodinated albumin through the toxin-damaged RWM was observed. We
propose that the passage of noxious macromolecules, such as proteases,
from a purulent middle-ear effusion may be facilitated by pore-forming
toxins, resulting in cochlear damage and sensorineural hearing loss.
A serious sequela of otitis media
(OM) is damage to the inner ear, leading to sensorineural hearing loss
(19, 22, 23), which is limited to the cochlea basal turn
(21). The etiology of sensorineural hearing loss has
remained elusive, but previous investigations indicate that
permeability of the three-layered round window membrane (RWM) is of
central importance (12, 25). Some studies have addressed the
effects of various bacterial products on the permeability of the RWM
(11-16), but bacterial cytolysins have largely been absent
from this list. To first provide information on the possible effects of
these toxins, we previously analyzed the effects of streptolysin-O
(SLO), the major cytotoxin elaborated by Streptococcus pyogenes
A, (1, 5, 6) on the permeability of resected RWMs in an
experimental system originally developed by Lundman et al.
(17). SLO was employed because this toxin is related
molecularly to pneumolysin, the major cytotoxin of Streptococcus
pneumoniae (1, 3, 5, 6, 8, 9, 24, 26) and is available
in highly purified form in our laboratory (4, 7, 27). When
the RWM surrounded by an intact bony frame was excised and embedded in
a Plexiglas sheet separating two buffer chambers, low concentrations of
SLO provoked rapid breakdown of the RWM permeability barrier. Fluxes of
Na+, [14C]mannitol, serum proteins, and
radioiodinated SLO were demonstrable (10).
It now became important to determine whether a flux of macromolecules
across toxin-damaged RWMs might indeed occur in vivo. To address this
question, we employed audioradiography and measurements of
radioactivity to detect the passage of iodinated SLO and albumin, respectively, from the middle to the inner ear.
Recombinant SLO was purified from Escherichia coli
(27). Solutions containing 20 µg of native SLO per ml
contained no detectable lipopolysaccharide as determined by a
quantitative Limulus assay (Kabi Vitrum Diagnostica,
Stockholm, Sweden). The proteins were stored lyophilized and
reconstituted with buffer plus 1% bovine serum albumin and 2 mM
dithiothreitol. The toxin was radioiodinated to a specific activity of
10 mCi/mg under retention of functional activity (20).
Thirty-five healthy guinea pigs (body weight, 250 to 400 g) were
used. Ear infection was excluded by the examination of the external
auditory canal and the tympanic membrane. Operations were undertaken
under general anesthesia with 80 mg of ketamine (50%) and 4 mg of
thiazine (5%) per kg of body weight and 0.1 ml of fentanyl. The bulla
was prepared and carefully opened by a standard retroauricular approach
(2). The tympanic membrane and auditory ossicles, except the
stapes, were removed, and the round window niche was exposed.
A total of 0.1 µCi of radioiodinated SLO plus 0.08 and 0.4 µg of
unlabeled SLO were applied to the round window niche in a volume of 0.1 ml of Hanks' balanced salt solution (HBSS) containing 1% bovine serum
albumin and 2 mM dithiothreitol. After 2 h, the round window niche
was washed with HBSS and the animal was sacrificed. The cochlea was
resected and fixed with an irrigation of 2% glutaraldehyde from the
round to the oval window (18). Then the cochlea was fixed
again, decalcified, embedded in paraffin, and cut into 10-µm sections. The sections were dipped in a Kodak NTD 3 photoemulsion, incubated for 14 days, and stained with methylene blue. In positive controls, radioiodinated SLO was directly applied into the cochlea and
so had immediate access to the cochlear epithelia and the organ of
Corti. Experiments with unlabelled SLO without tracer served as
negative controls.
In analogous experiments, 2,000,000 cpm of radioiodinated albumin plus
0.08, 0.4, or 2 µg of unlabelled SLO were applied in a volume of 0.1 ml to the round window niche. After 2 h, the round window niche
was washed with HBSS and the animal was sacrificed. The cochlear endo-
and perilymph were collected with a Hamilton syringe, and
radioactivity was determined in a gamma counter (Packard Cobra II).
Negative controls included animals that received radioiodinated albumin
into the round window niche without the use of SLO.
In the first experiments, we sampled the endo- and perilymph of the
cochlea following application of radioiodinated SLO to the RWM in the
presence of 0.08 to 2 µg of unlabelled toxin and albumin. However,
radioactivity was never recovered, indicating that the toxin could not
pass the membrane.
Autoradiography was then used to locate the tracer. As shown in control
autoradiographs, where radioiodinated SLO was directly applied into the
cochlea, the tracer produced a homogeneous distribution of grains along
all cochlear epithelia and the organ of Corti (Fig.
1). This demonstrated that SLO could bind
to target cell substrates in the inner ear. When the SLO tracer was
applied with 0.08 (n = 3) or 0.4 µg
(n = 11) of unlabelled SLO into the round window niche,
however, no radioactivity could be detected in the cochlea, and all of
the SLO tracer was detected in the middle-ear compartment (Fig.
2). This finding was consistent with the
lack of detectable flux of the radiotracer to the inner ear and showed that SLO quantitatively binds to target cells and becomes entrapped in
the middle-ear mucosa.
Albumin contrasts with SLO in displaying no affinity to cellular
structures. To assess flux of this molecule, direct measurement of
radioactivity in the peri- and endolymph was undertaken. No flux of
albumin occurred when the tracer was applied with 0.08 µg of SLO to
the middle ear. However, flux of the tracer was observed when 0.4 µg
of SLO was applied, and flux was massive when 2 µg of SLO was
employed (Fig. 3). As mentioned above, no
measurable flux of radiolabelled SLO was observed under the same
experimental conditions.
0019-9567/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Bacterial Cytolysin Perturbs Round Window Membrane Permeability
Barrier In Vivo: Possible Cause of Sensorineural Hearing Loss in
Acute Otitis Media
![]()
ABSTRACT
Top
Abstract
Text
References
![]()
TEXT
Top
Abstract
Text
References

View larger version (128K):
[in a new window]
FIG. 1.
Control autoradiography after direct application of
radioiodinated SLO into the cochlea. A homogeneous distribution of the
tracer (grains are indicated by an X) along all cochlear epithelia and
the organ of Corti (C) is revealed. E, endolymphatic space; P,
perilymphatic space (magnification, ×200).

View larger version (110K):
[in a new window]
FIG. 2.
SLO applied to the RWM does not enter the inner ear.
After the application of radioiodinated SLO plus 0.4 µg of unlabelled
SLO into the round window niche, no flow of the tracer can be
demonstrated. Only natural background activity is shown in the inner
ear (IE). The stria vascularis (SV) is dark due to its content of
melanocytes. Outside the cochlea, grains (indicated by an X) are
revealed, the middle-ear mucosa has entrapped the tracer. ME, middle
ear. Magnification, ×200.

View larger version (19K):
[in a new window]
FIG. 3.
Measurement of flux of radioiodinated albumin across the
RWMs. Radiolabelled albumin (2,000,000 cpm) was applied in a volume of
0.1 ml together with 0.08, 0.4, or 2 µg of SLO to the round window
niche. After 2 h, radioactivity in the endolymph was determined.
Values are means ± standard deviations (error bars)
(n = 4 in each group). The passage of albumin was
observed when 0.4 and 2.0 µg of SLO were applied with albumin.
These findings are the first to establish that a bacterial cytolysin can damage the RWM, causing leakage of macromolecules to the perilymph in situ. A priori, the concentration of SLO required to cause such massive breakdown of the RWM permeability barrier may appear high (4 to 20 µg/ml). However, a concentration of 20 µg/ml equates with only about 100 molecules of toxin per µm3, the approximate cytoplasmic volume of a gram-positive bacterium. In the case of pneumolysin, which is retained in the cytoplasm, far-higher concentrations must be present within the bacteria. It is thus of special interest first that pneumolysin is structurally and functionally similar to SLO and second that pneumolysin is produced by all pneumococcal strains, which are the most common cause of bacterial OM. In actual infections, it is therefore readily conceivable that autolysing bacteria located in immediate contact with the RWM will release sufficient quantities of their toxin to cause the gross permeability defects observed in this study. Ionic disequilibrium caused by ion fluxes could lead to severe disturbances of inner-ear functions, and the passage of macromolecules, such as bacterial proteases, may cause toxic damage to the organ of Corti. A simple explanation for the clinical syndrome of sensorineural hearing loss occurring during pneumococcal OM thus emerges. The present results indicate that the passage of cytolysins such as SLO or pneumolysin themselves would not be expected to contribute to disturbances of inner-ear function, because the toxins probably will become quantitatively entrapped in the middle ear due to their binding to cells lining this cavity. In the in vitro system used previously (10), the entire epithelial lining of the middle ear was absent, and the RWM alone may have been unable to trap all of the tracer, leading to the deviant finding compared to that of the present study. Thus, SLO could become a tool to transiently permeabilize the RWM, making possible the introduction of various agents into the inner ear.
| |
ACKNOWLEDGMENTS |
|---|
We thank the Medical-Experimental Center of the University of Leipzig for providing laboratory space, equipment, and experimental animals; Sigrid Weisheit, Medical-Experimental Center of the University, for kind and competent assistance; Renate Jendrek and Hildegard Gruschka, Paul-Flechsig-Institute of Brain Research, University of Leipzig, for performing histological sections and autoradiographies; and the Clinic for Nuclear Medicine, Leipzig, Germany, for performing the radioactivity measurements.
This study was supported by the Deutsche Forschungsgemeinschaft (PA 539/1-1).
| |
FOOTNOTES |
|---|
* Corresponding author. Mailing address: Institute of Medical Microbiology and Hygiene, Hochhaus am Augustusplatz, D-55101 Mainz, Germany. Phone: 6131 17-7341. Fax: 6131 39-2359. E-mail: makowiec{at}goofy.zdv.uni-mainz.de.
Editor: V. A. Fischetti
| |
REFERENCES |
|---|
|
|
|---|
| 1. | Alouf, E., and C. Geoffrey. 1991. The family of the antigenically-related, cholesterol-binding ("sulfhydryl-activated") cytolytic toxins, p. 147-186. In J. E. Alouf, and J. H. Freer (ed.), Sourcebook of bacterial protein toxins. Academic Press, Inc., New York, N.Y. |
| 2. | Asarch, R., M. Abramson, and V. B. Litton. 1975. Surgical anatomy of the guinea pig ear. Ann. Otol. 84:250-255. |
| 3. | Bernheimer, A. V. 1974. Interactions between membranes and cytolytic bacterial toxins. Biochim. Biophys. Acta 344:27-50. |
| 4. |
Bhakdi, S.,
M. Roth,
A. Sziegoleit, and J. Tranum-Jensen.
1984.
Isolation and identification of two hemolytic forms of streptolysin-O.
Infect. Immun.
46:394-400 |
| 5. | Bhakdi, S., and J. Tranum-Jensen. 1987. Damage to mammalian cells by proteins that form transmembrane pores. Rev. Physiol. Biochem. Pharmacol. 107:147-223[Medline]. |
| 6. | Bhakdi, S., and J. Tranum-Jensen. 1988. Damage to cell membranes by pore-forming bacterial cytolysins. Prog. Allergy 40:1-43[Medline]. |
| 7. |
Bhakdi, S.,
J. Tranum-Jensen, and A. Sziegoleit.
1985.
Mechanism of membrane damage by streptolysin-O.
Infect. Immun.
47:52-60 |
| 8. | Bhakdi, S., U. Weller, I. Walev, E. Martin, D. Jonas, and M. Palmer. 1993. A guide to the use of pore-forming toxins for controlled permeabilization of cell membranes. Med. Microbiol. Immunol. 182:167-175[Medline]. |
| 9. | Boulnois, G. J., T. J. Mitchell, F. K. Saunders, F. J. Mendez, and P. W. Andrew. 1990. Structure and function of pneumolysin, the thiol-activated toxin of Streptococcus pneumoniae. Zentralbl. Bakteriol. Suppl. 19:43-51. |
| 10. | Engel, F., R. Blatz, J. Kellner, M. Palmer, U. Weller, and S. Bhakdi. 1995. Breakdown of the round window membrane permeability barrier evoked by streptlysin-O: possible etiologic role in development of a sensorineural hearing loss in acute otitis media. Infect. Immun. 63:1305-1310[Abstract]. |
| 11. | Goycoolea, M. V., M. M. Paparella, B. Goldberg, P. M. Schlievert, and A. M. Carpenter. 1980. Permeability of the middle ear to staphylococcal pyrogenic exotoxin in otitis media. Int. J. Pediatr. Otorhinolaryngol. 1:301-308[Medline]. |
| 12. | Ikeda, K., and T. Morizono. 1988. Changes of the permeability of round window membrane in otitis media. Arch. Otolaryngol. Head Neck Surg. 114:895-897. |
| 13. | Ikeda, K., M. Sakagami, T. Morizono, and S. K. Juhn. 1990. Permeability of the round window membrane to middle-sized molecules in purulent otitis media. Arch. Otolaryngol. Head Neck Surg. 116:57-60. |
| 14. | Kawauchi, H., T. F. DeMaria, and D. J. Lim. 1988. Endotoxin permeability through the round window. Acta Oto-Laryngol. Suppl. 457:100-115. |
| 15. | Lundman, L., D. Bagger Sjoback, S. K. Juhn, and T. Morizono. 1992. Pseudomonas aeruginosa exotoxin A and Haemophilus influenzae type b endotoxin. Effect on the inner ear and passage through the round window membrane of the chinchilla. Acta Oto-Laryngol. Suppl. Stockh. 493:69-76. |
| 16. | Lundman, L., S. K. Juhn, D. Bagger Sjoback, and C. Svanborg. 1992. Permeability of the normal round window membrane to Haemophilus influenzae type b endotoxin. Acta Oto-Laryngol. 112:524-529[Medline]. |
| 17. | Lundman, L., D. Bagger Sjoback, L. Holmquist, and S. Juhn. 1989. Round window membrane permeability. An in vitro model. Acta Otolaryngol. Suppl. Stockh. 457:73-77. |
| 18. | McCormick, J. G., and A. L. Nutall. 1974. Auditory research, p. 281-297. In J. Wagner, and P. Manning (ed.), The biology of the guinea pig. Academic Press, Inc., New York, N.Y. |
| 19. | Morizono, T., G. S. Giebink, M. M. Paparella, M. A. Sikora, and D. Shea. 1985. Sensorineural hearing loss in experimental purulent otitis media due to Streptococcus pneumoniae. Arch. Otolaryngol. 12:794-798. |
| 20. | Palmer, M., A. Valeva, M. Kehoe, and S. Bhakdi. 1995. Kinetics of streptolysin-O self assembly. Eur. J. Biochem. 231:388-395[Medline]. |
| 21. | Paparella, M. M. 1984. Review of sensorineural hearing loss. Am. J. Otolaryngol. 5:311-314. |
| 22. | Paparella, M. M., M. Goycoolea, P. A. Schachern, and H. Sajjadi. 1987. Current clinical and pathological features of round window diseases. Laryngoscope 97:1151-1160[Medline]. |
| 23. | Paparella, M. M., T. Morizono, C. T. Le, F. Mancini, P. Sipila, Y. B. Choo, G. Liden, and C. S. Kim. 1984. Sensorineural hearing loss in otitis media. Ann. Otol. Rhinol. Laryngol. 93:623-629[Medline]. |
| 24. | Paton, J. C., P. W. Andrew, G. J. Boulnois, and T. J. Mitchell. 1993. Molecular analysis of the pathogenicity of Streptococcus pneumoniae: the role of pneumococcal proteins. Annu. Rev. Microbiol. 47:89-115[Medline]. |
| 25. | Schachern, P. A., M. M. Paparella, and M. Goycoolea. 1987. The permeability of the round window membrane during otitis media. Arch. Otalaryngol. Head Neck Surg. 113:625-629. |
| 26. |
Walker, J. A.,
R. L. Allen,
P. Falmagne,
M. K. Johnson, and G. J. Boulnois.
1987.
Molecular cloning, characterization and complete nucleotide sequence of the gene for pneumolysin, the sulfhydryl-activated toxin of Streptococcus pneumoniae.
Infect. Immun.
55:1184-1189 |
| 27. | Weller, U., L. Müller, M. Messner, M. Palmer, A. Valva, J. Tranum-Jensen, P. Agrawal, C. Biermann, A. Dobereiner, M. A. Kehoe, and S. A. Bhakdi. 1996. Expression of active streptolysin-O in Escherichia coli as a maltose-binding protein streptolysin-O fusion protein. The N-terminal 70 amino acids are not required for hemolytic activity. Eur. J. Biochem. 236:34-39[Medline]. |
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»